PD-L1 is available in the plasma of HNSCC patients both as soluble molecule or carried by exosomes, and the presence of PD-L1+ exosomes has been correlated with the increased immune suppressive state of these patients (Theodoraki et al., 2018). This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.